Colon signet-ring cell carcinoma with chylous ascites caused by immunosuppressants following liver transplantation: A case report

doi:10.4240/wjgs.v16.i7.2343

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (861)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

WORD

HTML

464

Figures (1-6)

148

Sum=643

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

158

Sum=187

Jul 27, 2024 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Surg. Jul 27, 2024; 16(7): 2343-2350
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2343

Colon signet-ring cell carcinoma with chylous ascites caused by immunosuppressants following liver transplantation: A case report

Ying Li, Yang Tai, Hao Wu

Ying Li, Yang Tai, Hao Wu, Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China

Co-first authors: Ying Li and Yang Tai.

Author contributions: Li Y and Tai Y acquired the clinical data and produced the initial draft; Wu H reviewed and edited the manuscript. All authors have read and approved the final manuscript. Li Y and Tai Y contributed equally to this work as co-first authors.

Supported by National Natural Science Foundation of China, No. 82270649.

Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.

Conflict-of-interest statement: The authors declare that they have no conflicts of interest to disclose.

CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Hao Wu, PhD, Doctor, Professor, Department of Gastroenterology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu 610041, Sichuan Province, China. hxxhwh@163.com

Received: April 6, 2024
Revised: May 23, 2024
Accepted: June 12, 2024
Published online: July 27, 2024
Processing time: 106 Days and 21.1 Hours

Core Tip

Core Tip: Chylous ascites can be caused by various etiologies, among which cirrhosis, malignancy and tuberculosis are the most common. However, colon signer ring cell carcinoma secondary to use of immunosuppressants is rare in cirrhotic patients after liver transplantation, and these patients are easily prone to misdiagnosis and missed diagnosis. We report a case of chylous ascites caused by colon signer ring cell carcinoma due to the use of immunosuppressants after liver transplantation. Clinical alerts should be raised to determine whether the etiology of chylous ascites is related to carcinoma in patients who have been administered immunosuppressants after liver transplantation.